Possible Role of Roflumilast in Diabetic Nephropathy

NCT04755946 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathies

Interventions

DRUG: Roflumilast
DRUG: Placebo

Sponsor

Tanta University